StockData
Century Therapeutics, Inc. logo

Century Therapeutics, Inc. (IPSC) stock

IPSCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.64−0.01 (-0.61%)

Close on Nov 16, 2026Market cap $296.96MP/E –Yield –

Century Therapeutics cash

Cash and short-term investments held at the end of each period.

Century Therapeutics's cash was $119.71M at Jun 30, 2026. For fiscal 2025 it was $117.11M, down 39.0% from the year before. The highest annual figure on record is $317.48M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$117.11M-39.0%
FY2024Dec 31, 2024$192.06M+9.9%
FY2023Dec 31, 2023$174.72M-45.0%
FY2022Dec 31, 2022$317.48M+41.4%
FY2021Dec 31, 2021$224.60M+194.5%
FY2020Dec 31, 2020$76.27M+73.1%
FY2019Dec 31, 2019$44.06M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$119.71M-24.5%
Q1 FY2026Mar 31, 2026$134.80M-19.7%
Q4 FY2025Dec 31, 2025$117.11M-39.0%
Q3 FY2025Sep 30, 2025$132.75M-33.9%
Q2 FY2025Jun 30, 2025$158.55M-20.4%
Q1 FY2025Mar 31, 2025$167.90M-13.5%
Q4 FY2024Dec 31, 2024$192.06M+9.9%
Q3 FY2024Sep 30, 2024$200.95M+17.2%
Q2 FY2024Jun 30, 2024$199.24M+25.8%
Q1 FY2024Mar 31, 2024$194.00M-23.5%
Q4 FY2023Dec 31, 2023$174.72M-45.0%
Q3 FY2023Sep 30, 2023$171.48M-52.1%
Q2 FY2023Jun 30, 2023$158.38M-58.4%
Q1 FY2023Mar 31, 2023$253.45M-30.1%
Q4 FY2022Dec 31, 2022$317.48M+41.4%
Q3 FY2022Sep 30, 2022$357.84M+20.5%
Q2 FY2022Jun 30, 2022$380.74M-4.8%
Q1 FY2022Mar 31, 2022$362.74M+353.4%
Q4 FY2021Dec 31, 2021$224.60M+194.5%
Q3 FY2021Sep 30, 2021$296.87M+1156.4%
Q2 FY2021Jun 30, 2021$399.80M+1655.3%
Q1 FY2021Mar 31, 2021$80.00M+81.6%
Q4 FY2020Dec 31, 2020$76.27M–
Q3 FY2020Sep 30, 2020$23.63M–
Q2 FY2020Jun 30, 2020$22.78M–
Q4 FY2019Dec 31, 2019$44.06M–

More Century Therapeutics figures

See a number that looks wrong?